… García-Sastre) from Mount Sinai Philanthropy, awards (S10OD018522 and S10OD026880)
from the NIH Office of Research Infrastructure Programs, and a Robin Chemers Neustein …

Here, we describe a serological enzyme-linked immunosorbent assay for the screening and
identification of human SARS-CoV-2 seroconverters. This assay does not require the …

The recent emergence of B.1.1.529, the Omicron variant 1 , 2 , has raised concerns of
escape from protection by vaccines and therapeutic antibodies. A key test for potential …

A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which is the causative agent of coronavirus disease 2019 (COVID-19), has …

The interface between an infectious agent and its host represents the ultimate battleground
for survival: The microbe must secure a niche for replication, whereas the host must limit the …

We have rescued influenza A virus by transfection of 12 plasmids into Vero cells. The eight
individual negative-sense genomic viral RNAs were transcribed from plasmids containing …

INTRODUCTION Clinical outcomes of human severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection range from silent infection to lethal coronavirus disease 2019 (…

Despite accumulating evidence suggesting local self-maintenance of tissue macrophages
in the steady state, the dogma remains that tissue macrophages derive from monocytes. …

Alpha/beta interferon immune defenses are essential for resistance to viruses and can be
triggered through the actions of the cytoplasmic helicases retinoic acid-inducible gene I (RIG-I) …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of
coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the …